Ryan et al. in their study tested the effect of the GI on postprandial glycemic variations in children with T1D and CGM, receiving multiple daily injections and determined the optimal insulin therapy for a low-GI meal. This evidence concerns the gene INS and type 1 diabetes mellitus.